Comment

Comment by Dr. Krishna Kumari Challa on November 26, 2021 at 11:10am

As for COVID-19 vaccines, the primary antigen used is the SARS-CoV-2 spike protein. According to Murphy and Longo, current research studies on antibody responses to these vaccines mainly focus on the initial protective responses and virus-neutralizing efficacy, rather than other long-term aspects.

"With the incredible impact of the pandemic and our reliance on vaccines as our primary weapon, there is an immense need for more basic science research to understand the complex immunological pathways at play. This need follows to what it takes to keep the protective responses going, as well as to the potential unwanted side effects of both the infection and the different SARS-CoV-2 vaccine types, especially as boosting is now applied. "The good news is that these are testable questions that can be partially addressed in the laboratory, and in fact, have been used with other viral models."

 William J. Murphy et al, A Possible Role for Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination, New England Journal of Medicine (2021). DOI: 10.1056/NEJMcibr2113694

https://medicalxpress.com/news/2021-11-antibodies-mimicking-virus-h...

Part 3

**

Comment by Dr. Krishna Kumari Challa on November 26, 2021 at 11:08am

Antibodies mimicking the virus

Drawing upon classic immunological concepts, Murphy and Longo suggest that the Network Hypothesis by Nobel Laureate Niels Jerne might offer insights.

Jerne's hypothesis details a means for the immune system to regulate antibodies. It describes a cascade in which the immune system initially launches protective antibody responses to an antigen (like a virus). These same protective antibodies later can trigger a new antibody response toward themselves, leading to their disappearance over time.

These secondary antibodies, called anti-idiotype antibodies, can bind to and deplete the initial protective antibody responses. They have the potential to mirror or act like the original antigen itself. This may result in adverse effects.

Coronavirus and the immune system

When SARS-CoV-2, the virus causing COVID-19, enters the body, its spike protein binds with the ACE2 receptor, gaining entry to the cell. The immune system responds by producing protective antibodies that bind to the invading virus, blocking or neutralizing its effects.

As a form of down-regulation, these protective antibodies can also cause immune responses with anti-idiotype antibodies. Over time, these anti-idiotype responses can clear the initial protective antibodies and potentially result in limited efficacy of antibody-based therapies.

"A fascinating aspect of the newly formed anti-idiotype antibodies is that some of their structures can be a mirror image of the original antigen and act like it in binding to the same receptors that the viral antigen binds. This binding can potentially lead to unwanted actions and pathology, particularly in the long term.

The authors suggest that the anti-idiotype antibodies can potentially target the same ACE2 receptors. In blocking or triggering these receptors, they could affect various normal ACE2 functions.

"Given the critical functions and wide distribution of ACE2 receptors on numerous cell types, it would be important to determine if these regulatory immune responses could be responsible for some of the off-target or long-lasting effects being reported. These responses may also explain why such long-term effects can occur long after the viral infection has passed.

Part 2

Comment by Dr. Krishna Kumari Challa on November 26, 2021 at 11:06am

Antibodies mimicking the virus may explain long haul COVID-19, rare vaccine side effects

The COVID-19 pandemic has challenged scientists and those in the medical field. Researchers are working to find effective vaccines and therapies, as well as understand the long-term effects of the infection.

While the vaccines have been critical in pandemic control, researchers are still learning how and how well they work. This is especially true with the emergence of new viral variants and the rare vaccine side effects like allergic reactions, heart inflammation (myocarditis) and blood-clotting (thrombosis).

Critical questions about the infection itself also remain. Approximately one in four COVID-19 patients have lingering symptoms, even after recovering from the virus. These symptoms, known as "long COVID," and the vaccines' off-target side effects are thought to be due to a patient's immune response.

In an article published recently in The New England Journal of Medicine, scientists present a possible explanation to the diverse immune responses to the virus and the vaccines.

Part 1

Comment by Dr. Krishna Kumari Challa on November 26, 2021 at 10:19am

‘Super jelly’ can survive being run over by a car

Researchers have developed a jelly-like material that can withstand the equivalent of an elephant standing on it, and completely recover to its original shape, even though it’s 80% water.

The soft-yet-strong material, developed by a team at the University of Cambridge, looks and feels like a squishy jelly, but acts like an ultra-hard, shatterproof glass when compressed, despite its high water content.

The non-water portion of the material is a network of polymers held together by reversible on/off interactions that control the material’s mechanical properties. This is the first time that such significant resistance to compression has been incorporated into a soft material.

The ‘super jelly’ could be used for a wide range of potential applications, including soft robotics, bioelectronics or even as a cartilage replacement for biomedical use. The results are reported in the journal Nature Materials.

https://www.nature.com/articles/s41563-021-01124-x

Comment by Dr. Krishna Kumari Challa on November 25, 2021 at 10:43am

Tracing down why these alternate genetic codes emerged during evolutionary history is difficult, multiple researchers tell The Scientist, in no small part because humans couldn’t watch it happen. But the authors do have some hypotheses.

 a bacterium that uses the same alternate code as a bacteriophage virus that infects it, indicating that the bacteria seemingly evolved an alternate code that prevented its cellular machinery from being hijacked—and that the phage may have then made the same adaptation to follow its host.

https://www.the-scientist.com/news-opinion/screen-of-250-000-specie...

Comment by Dr. Krishna Kumari Challa on November 25, 2021 at 10:41am

Screen of 250,000 Species Reveals Tweaks to Genetic Code

A massive screen of bacterial and archaeal genomes revealed five previously unknown instances where an organism uses an alternate code to translate genetic blueprints into proteins.

he genetic code that dictates how genetic information is translated into specific proteins is less rigid than scientists have long assumed, according to research published today (November 9) in eLife. In the paper, scientists report screening the genomes of more than 250,000 species of bacteria and archaea and finding five organisms that rely on an alternate genetic code, signifying branches in evolutionary history that haven’t been fully explained.

The genetic code refers to how sequences of DNA nucleotide bases lead to specific chains of amino acids during the process of protein synthesis. To perform this synthesis, ribosomes read strands of mRNA—copies of bits of the organism’s genome—in chunks of three bases at a time. Each three-base sequence, known as a codon, binds to a specific transfer RNA (tRNA) that ferries a corresponding amino acid to the ribosome to the added to the protein chain. An organism with an alternate genetic code, like the five new instances that the study authors found, has codons that correspond to different amino acids than they would in the standard genetic code employed by the vast majority of known life forms.

The genetic code has been set in stone for 3 billion years. The fact that some organisms have found a way to change it is really fascinating . Changing the genetic code requires changing ancient, important molecules like tRNAs that are so fundamental to how biology works.

As such, the code was thought to be largely preserved across all forms of life, with scientists finding the occasional exception during the past several decades of research. In addition to finding five new alternate genetic codes, the team also verified seven others that had been discovered one-by-one in the past, bringing the total number of known exceptions in bacteria to 12.

Part of the reason changes do happen is that some bacterial genomes may have a low composition of certain nucleotides compared to others. That brings the usage of codons that rely on those nucleotides down to nearly zero, making it easier for an organism to survive shifts without altering too many proteins in a drastic way.

Part 1

Comment by Dr. Krishna Kumari Challa on November 25, 2021 at 9:36am

Can scientists save the world?

What is wrong with trying?

Nasa scientists have launched a spacecraft to test out new technology that could stop the Earth being hit by a deadly asteroid. By crashing it into a small asteroid, they hope to be able to perfect a technique of crashing it into any large object that is heading towards our planet, changing the course of its trajectory.

Comment by Dr. Krishna Kumari Challa on November 25, 2021 at 8:46am

The retina's photoreceptor population is formed of cones, which mediate color vision, and rods, which adapt vision in low/dim light. This study focused on cones and observed color contrast sensitivity, along the protan axis (measuring red-green contrast) and the tritan axis (blue-yellow).

All the participants were aged between 34 and 70, had no ocular disease, completed a questionnaire regarding eye health prior to testing, and had normal color vision (cone function). This was assessed using a 'Chroma Test': identifying colored letters that had very low contrast and appeared increasingly blurred, a process called color contrast.

Using a provided LED device all 20 participants (13 female and 7 male) were exposed to three minutes of 670nm deep red light in the morning between 8am and 9am. Their color vision was then tested again three hours post exposure and 10 of the participants were also tested one week post exposure.

On average there was a 'significant' 17% improvement in color vision, which lasted a week in tested participants; in some older participants there was a 20% improvement, also lasting a week.

A few months on from the first test (ensuring any positive effects of the deep red light had been 'washed out') six (three female, three male) of the 20 participants, carried out the same test in the afternoon, between 12pm to 1pm. When participants then had their color vision tested again, it showed zero improvement.

Morning exposure is absolutely key to achieving improvements in declining vision: as we have previously seen in flies, mitochondria have shifting work patterns and do not respond in the same way to light in the afternoon—this study confirms this.

Weeklong improved colour contrasts sensitivity after single 670nm exposures associated with enhanced mitochondrial function, Scientific Reports (2021). DOI: 10.1038/s41598-021-02311-1

https://medicalxpress.com/news/2021-11-morning-exposure-deep-red-de...

Part 3

Comment by Dr. Krishna Kumari Challa on November 25, 2021 at 8:45am

In humans around 40 years old, cells in the eye's retina begin to age, and the pace of this aging is caused, in part, when the cell's mitochondria, whose role is to produce energy (known as ATP) and boost cell function, also start to decline.

Mitochondrial density is greatest in the retina's photoreceptor cells, which have high energy demands. As a result, the retina ages faster than other organs, with a 70% ATP reduction over life, causing a significant decline in photoreceptor function as they lack the energy to perform their normal role.

In studying the effects of deep red light in humans, researchers built on their previous findings in mice, bumblebees and fruit flies, which all found significant improvements in the function of the retina's photoreceptors when their eyes were exposed to 670 nanometre (long wavelength) deep red light.

"Mitochondria have specific sensitivities to long wavelength light influencing their performance: longer wavelengths spanning 650 to 900nm improve mitochondrial performance to increase energy production.

part 2

Comment by Dr. Krishna Kumari Challa on November 25, 2021 at 8:44am

Morning exposure to deep red light improves declining eyesight

Just three minutes of exposure to deep red light once a week, when delivered in the morning, can significantly improve declining eyesight, finds a pioneering new study by UCL researchers.

Published in Scientific Reports, the study builds on the team's previous work, which showed daily three-minute exposure to longwave deep red light 'switched on' energy producing mitochondria cells in the human retina, helping boost naturally declining vision.

For this latest study, scientists wanted to establish what effect a single three-minute exposure would have, while also using much lower energy levels than their previous studies. Furthermore, building on separate UCL research in flies that found mitochondria display 'shifting workloads' depending on the time of day, the team compared morning exposure to afternoon exposure.

Researchers found there was, on average, a 17% improvement in participants' color contrast vision when exposed to three minutes of 670 nanometre (long wavelength) deep red light in the morning and the effects of this single exposure lasted for at least a week. However, when the same test was conducted in the afternoon, no improvement was seen.

Scientists say the benefits of deep red light, highlighted by the findings, mark a breakthrough for eye health and should lead to affordable home-based eye therapies, helping the millions of people globally with naturally declining vision.

Part 1

• ‹ Previous
• 1
• …
• 546
• 547
• 548
• 549
• 550
• …
• 1079
• Next ›
• Page